Statements (28)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:drug
|
gptkbp:acetaminophenStrength |
300 mg
|
gptkbp:activeIngredient |
gptkb:codeine_phosphate
acetaminophen |
gptkbp:availableByPrescription |
yes
|
gptkbp:brand |
acetaminophen/codeine combination
|
gptkbp:codeineStrength |
60 mg
|
gptkbp:contraindication |
severe liver disease
hypersensitivity to codeine hypersensitivity to acetaminophen |
gptkbp:controlledSubstanceSchedule |
gptkb:Schedule_III_(US)
|
gptkbp:form |
gptkb:tablet
|
https://www.w3.org/2000/01/rdf-schema#label |
Tylenol #4
|
gptkbp:legalStatus |
prescription only
|
gptkbp:manufacturer |
gptkb:Johnson_&_Johnson
|
gptkbp:marketedIn |
gptkb:Canada
gptkb:United_States |
gptkbp:pregnancyCategory |
C (US)
|
gptkbp:riskFactor |
liver toxicity
dependence |
gptkbp:routeOfAdministration |
oral
|
gptkbp:sideEffect |
nausea
constipation dizziness drowsiness |
gptkbp:usedFor |
pain relief
|
gptkbp:bfsParent |
gptkb:Tylenol_with_codeine
|
gptkbp:bfsLayer |
7
|